337 related articles for article (PubMed ID: 15943987)
1. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
2. Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells.
Abendstein B; Stadlmann S; Knabbe C; Buck M; Müller-Holzner E; Zeimet AG; Marth C; Obrist P; Krugmann J; Offner FA
Cytokine; 2000 Jul; 12(7):1115-9. PubMed ID: 10880260
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.
Offner FA; Feichtinger H; Stadlmann S; Obrist P; Marth C; Klingler P; Grage B; Schmahl M; Knabbe C
Am J Pathol; 1996 May; 148(5):1679-88. PubMed ID: 8623935
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells.
Zeimet AG; Offner FA; Marth C; Heim K; Feichtinger H; Daxenbichler G; Dapunt O
Anticancer Res; 1997; 17(4B):3129-31. PubMed ID: 9329618
[TBL] [Abstract][Full Text] [Related]
7. [Effects of human peritoneal mesothelial cells on angiogenesis factor expression and secretion of ovarian carcinoma cells].
Zhang JJ; Wang B; Liu ZJ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):737-40. PubMed ID: 17366783
[TBL] [Abstract][Full Text] [Related]
8. Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.
Yoshino Y; Aoyagi M; Tamaki M; Duan L; Morimoto T; Ohno K
Int J Oncol; 2006 Oct; 29(4):981-7. PubMed ID: 16964394
[TBL] [Abstract][Full Text] [Related]
9. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells.
Offner FA; Obrist P; Stadlmann S; Feichtinger H; Klingler P; Herold M; Zwierzina H; Hittmair A; Mikuz G; Abendstein B
Cytokine; 1995 Aug; 7(6):542-7. PubMed ID: 8580370
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.
Pérez-Ruiz M; Ros J; Morales-Ruiz M; Navasa M; Colmenero J; Ruiz-del-Arbol L; Cejudo P; Clária J; Rivera F; Arroyo V; Rodés J; Jiménez W
Hepatology; 1999 Apr; 29(4):1057-63. PubMed ID: 10094946
[TBL] [Abstract][Full Text] [Related]
11. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1beta regulates vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts.
Nasu K; Itoh H; Yuge A; Kawano Y; Yoshimatsu J; Narahara H
Gynecol Endocrinol; 2006 Sep; 22(9):495-500. PubMed ID: 17071533
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
[TBL] [Abstract][Full Text] [Related]
15. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125.
Zeimet AG; Marth C; Offner FA; Obrist P; Uhl-Steidl M; Feichtinger H; Stadlmann S; Daxenbichler G; Dapunt O
Gynecol Oncol; 1996 Sep; 62(3):384-9. PubMed ID: 8812537
[TBL] [Abstract][Full Text] [Related]
16. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
Zhang JJ; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
[TBL] [Abstract][Full Text] [Related]
17. Response of human peritoneal mesothelial cells to inflammatory injury is regulated by interleukin-1beta and tumor necrosis factor-alpha.
Stadlmann S; Pollheimer J; Renner K; Zeimet AG; Offner FA; Amberger A
Wound Repair Regen; 2006; 14(2):187-94. PubMed ID: 16630108
[TBL] [Abstract][Full Text] [Related]
18. Expression of IL-10 in patients with ovarian carcinoma.
Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
[TBL] [Abstract][Full Text] [Related]
19. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
Belotti D; Paganoni P; Manenti L; Garofalo A; Marchini S; Taraboletti G; Giavazzi R
Cancer Res; 2003 Sep; 63(17):5224-9. PubMed ID: 14500349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
